Showing results (581-590 of 619) with videos related to

Sort By:
Pageof 62
International Journal of Antimicrobial Agents|April 23, 2026
Population pharmacokinetics of polymyxin B in critically ill patients with multidrug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infectionsPuteri Juanita Zamri, Saskia A Wölky, Maria P Hernandez-Mitre, et al.
The American Journal of Tropical Medicine and Hygiene|December 5, 2008
Dengue virus-infected Aedes aegypti in the home environmentJulian Garcia-Rejon, Maria Alba Loroño-Pino, Jose Arturo Farfan-Ale, et al.
Elife|April 28, 2020
A tudor domain protein, SIMR-1, promotes siRNA production at piRNA-targeted mRNAs in C. elegansKevin I Manage, Alicia K Rogers, Dylan C Wallis, et al.
Intensive Care Medicine Experimental|July 13, 2018
A research pathway for the study of the delivery and disposition of nebulised antibiotics: an incremental approach from in vitro to large animal modelsJayesh A Dhanani, Jeremy Cohen, Suzanne L Parker, et al.
Scientific Reports|October 30, 2025
Meropenem dosing optimization on day 1 and steady state in critically ill patients without significant renal impairmentHelmi Sulaiman, Muhammad Azrai Rozali, Santosh K S Adiraju, et al.
BMC Infectious Diseases|March 3, 2016
SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patientsJason A Roberts, Gordon Y S Choi, Gavin M Joynt, et al.
The American Journal of Tropical Medicine and Hygiene|November 2, 2004
Introduction of the American/Asian genotype of dengue 2 virus into the Yucatan State of MexicoMaría A Loroño-Pino, José A Farfán-Ale, Alicia L Zapata-Peraza, et al.
The American Journal of Tropical Medicine and Hygiene|June 5, 2013
Towards a Casa Segura: a consumer product study of the effect of insecticide-treated curtains on Aedes aegypti and dengue virus infections in the homeMaría Alba Loroño-Pino, Julián E García-Rejón, Carlos Machain-Williams, et al.
Antibiotics (Basel, Switzerland)|January 21, 2022
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection ModelJessica R Tait, Hajira Bilal, Kate E Rogers, et al.
International Journal of Antimicrobial Agents|March 18, 2014
Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: lessons from the DALI StudyJ A Roberts, V Stove, J J De Waele, et al.
Pageof 62